FTC (US Federal Trade Commission) concerns delay Quest/Unilab deal again
This article was originally published in Clinica
Executive Summary
Quest Diagnostics has once again extended its $1.1bn exchange offer for Unilab, the Californian clinical laboratory testing services organisation, as discussions with the US Federal Trade Commission (FTC) continue over antitrust issues continue.